Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 3/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL534062 | 0.90 | ERAP1 (0.52) | ALDH1A1NPSR1KMT2ASMN1; SMN2GAA | |
| SCHEMBL533043 | 0.88 | ALDH1A1 (0.43) | ALDH1A1NPSR1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL14288678 | 0.88 | ALDH1A1 (0.52) | ALDH1A1NPSR1KMT2ASMN1; SMN2MAPK1 | |
| SCHEMBL534065 | 0.88 | PKM (0.53) | KMT2ASMN1; SMN2GAAL3MBTL1 | |
| SCHEMBL533016 | 0.85 | ALPL (0.49) | ALDH1A1MAPTTP53L3MBTL1 | |
| SCHEMBL532953 | 0.84 | FFAR4 (0.59) | ALDH1A1MAPTKMT2ASMN1; SMN2MEN1 | |
| SCHEMBL533112 | 0.83 | ALPL (0.46) | ALDH1A1MAPTKMT2ARECQLTP53 | |
| SCHEMBL532936 | 0.83 | MCOLN3 (0.51) | ALDH1A1KMT2ASMN1; SMN2MAPK1TP53 | |
| SCHEMBL532832 | 0.82 | FFAR4 (0.60) | ALDH1A1MAPTSMN1; SMN2TP53LMNA | |
| SCHEMBL533460 | 0.79 | ALDH1A1 (0.42) | ALDH1A1NPSR1MAPTKMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2415760-A2 | CCR-9 antagonists | ENCYSIVE PHARMACEUTICALS, INC. (US) | 2012-02-08 | — | — | EP | disclosed |
| US-7319111-B2 | Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists | ENCYSIVE PHARMACEUTICALS, INC. (US) | 2008-01-15 | — | — | US | disclosed |
| US-7319111-B2 | Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists | ENCYSIVE PHARMACEUTICALS, INC. (US) | 2008-01-15 | — | — | US | disclosed |
| US-7319111-B2 | Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists | ENCYSIVE PHARMACEUTICALS, INC. (US) | 2008-01-15 | — | — | US | disclosed |